Paper37765331
Advances in Pancreatic Cancer Treatment by Nano-Based Drug Delivery Systems.
Viegas C and 6 others. Pharmaceutics, 2023. Cited by 36 papers, by iCite.
Cite this record
ConductScience Library. Advances in Pancreatic Cancer Treatment by Nano-Based Drug Delivery Systems. Papers, record 37765331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37765331
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants7
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| UIDB/04326/2020 | Fundação para a Ciência e Tecnologia | PubMed | ||
| UIDP/04326/2020 | Fundação para a Ciência e Tecnologia | PubMed | ||
| LA/P/0101/2020 | Fundação para a Ciência e Tecnologia | PubMed | ||
| UIDB/04565/2020 | Fundação para a Ciência e Tecnologia | PubMed | ||
| UIDP/04565/2020 | Fundação para a Ciência e Tecnologia | PubMed | ||
| LA/P/0140/2020 | Fundação para a Ciência e Tecnologia | PubMed | ||
| 2020.08839.BD | Fundação para a Ciência e Tecnologia | PubMed |
Source PubMed
References183
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 20198462 | Pancreatic cancer: pathobiology, treatment options, and drug delivery. | AAPS J | 2010 | https://conductscience.org/library/papers/20198462 | PubMed |
| 2 | 21412497 | Advances in diagnosis, treatment and palliation of pancreatic carcinoma: 1990-2010. | World J Gastroenterol | 2011 | https://conductscience.org/library/papers/21412497 | PubMed |
| 3 | 25099181 | Chromogranin A is a reliable serum diagnostic biomarker for pancreatic neuroendocrine tumors but not for insulinomas. | BMC Endocr Disord | 2014 | https://conductscience.org/library/papers/25099181 | PubMed |
| 4 | 24871552 | The practicality of mesoporous silica nanoparticles as drug delivery devices and progress toward this goal. | AAPS PharmSciTech | 2014 | https://conductscience.org/library/papers/24871552 | PubMed |
| 5 | 25273092 | Preclinical activity of nanoliposomal irinotecan is governed by tumor deposition and intratumor prodrug conversion. | Cancer Res | 2014 | https://conductscience.org/library/papers/25273092 | PubMed |
| 6 | 29662668 | Proteomic biomarkers in body fluids associated with pancreatic cancer. | Oncotarget | 2018 | https://conductscience.org/library/papers/29662668 | PubMed |
| 7 | 24163786 | Paclitaxel Nano-Delivery Systems: A Comprehensive Review. | J Nanomed Nanotechnol | 2013 | https://conductscience.org/library/papers/24163786 | PubMed |
| 8 | 6141560 | Inhibition of growth of pancreatic carcinomas in animal models by analogs of hypothalamic hormones. | Proc Natl Acad Sci U S A | 1984 | https://conductscience.org/library/papers/6141560 | PubMed |
| 9 | 2482253 | Integrated actions of cholecystokinin on the gastrointestinal tract: use of the cholecystokinin bioassay. | Gastroenterol Clin North Am | 1989 | https://conductscience.org/library/papers/2482253 | PubMed |
| 10 | 25319803 | Stimuli-responsive polymeric nanoparticles for nanomedicine. | ChemMedChem | 2015 | https://conductscience.org/library/papers/25319803 | PubMed |
| 11 | 26812903 | European cancer mortality predictions for the year 2016 with focus on leukaemias. | Ann Oncol | 2016 | https://conductscience.org/library/papers/26812903 | PubMed |
| 12 | 32208984 | Sonication tailored enhance cytotoxicity of naringenin nanoparticle in pancreatic cancer: design, optimization, and in vitro studies. | Drug Dev Ind Pharm | 2020 | https://conductscience.org/library/papers/32208984 | PubMed |
| 13 | 30999154 | Superparamagnetic iron oxide nanoparticles of curcumin enhance gemcitabine therapeutic response in pancreatic cancer. | Biomaterials | 2019 | https://conductscience.org/library/papers/30999154 | PubMed |
| 14 | 21969517 | Gemcitabine plus nab-paclitaxel is an active regimen in patients with advanced pancreatic cancer: a phase I/II trial. | J Clin Oncol | 2011 | https://conductscience.org/library/papers/21969517 | PubMed |
| 15 | 28850089 | Magnetic Nanoparticles: From Design and Synthesis to Real World Applications. | Nanomaterials (Basel) | 2017 | https://conductscience.org/library/papers/28850089 | PubMed |
| 16 | 27299311 | Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date. | Pharm Res | 2016 | https://conductscience.org/library/papers/27299311 | PubMed |
| 17 | 26185420 | Pancreatic cancer: optimizing treatment options, new, and emerging targeted therapies. | Drug Des Devel Ther | 2015 | https://conductscience.org/library/papers/26185420 | PubMed |
| 18 | 27531700 | Nanomedicine strategies to overcome the pathophysiological barriers of pancreatic cancer. | Nat Rev Clin Oncol | 2016 | https://conductscience.org/library/papers/27531700 | PubMed |
| 19 | 27284250 | Onivyde for the therapy of multiple solid tumors. | Onco Targets Ther | 2016 | https://conductscience.org/library/papers/27284250 | PubMed |
| 20 | 22425961 | Overcoming nucleoside analog chemoresistance of pancreatic cancer: a therapeutic challenge. | Cancer Lett | 2012 | https://conductscience.org/library/papers/22425961 | PubMed |
Cited by23
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 36 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42873039 | From Nature to Medicine: Overcoming the Limitations of Herbal Therapeutics for Pancreatic Cancer Treatment Based on Nanotechnology. | Nanomaterials (Basel) | 2026 | https://conductscience.org/library/papers/42873039 | PubMed |
| 42816651 | Inhibition of pancreatic cancer growth by an siRNA targeting SNORA22 and a folic acid-conjugated cationic oligopeptide. | Hum Cell | 2026 | https://conductscience.org/library/papers/42816651 | PubMed |
| 42639199 | Ferroptosis-Based Nanotherapy for Pancreatic Ductal Adenocarcinoma Through Glutathione Depletion and Iron Accumulation. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42639199 | PubMed |
| 42215504 | The cationic nanoliposomes loaded with asymmetric PCR product targeting PTK6 mRNA and induce apoptosis in PANC-1 cells. | Sci Rep | 2026 | https://conductscience.org/library/papers/42215504 | PubMed |
| 42120783 | Bridging Therapeutics and Nanotechnology in Dry Eye Disease: A Review of Risk Factors, Drug Delivery Barriers, and Recent and Future Endeavors for Disease Management. | AAPS PharmSciTech | 2026 | https://conductscience.org/library/papers/42120783 | PubMed |
| 42062704 | uPAR-targeted stealth small-sized mesoporous silica nanoparticles for pancreatic cancer therapy. | Drug Deliv Transl Res | 2026 | https://conductscience.org/library/papers/42062704 | PubMed |
| 41869550 | Smart polymeric nanoparticles for targeted delivery and microenvironment-responsive therapy in pancreatic cancer. | Smart Mater Med | 2025 | https://conductscience.org/library/papers/41869550 | PubMed |
| 41580747 | Recent advances in nanomaterial-based precision medicine for orthotopic tumor therapy. | J Nanobiotechnology | 2026 | https://conductscience.org/library/papers/41580747 | PubMed |
| 41293487 | Recent advances in hydrogel-based delivery systems for the treatment of pancreatic cancer. | Mater Today Bio | 2025 | https://conductscience.org/library/papers/41293487 | PubMed |
| 41219654 | Utilizing Hot-Melt Extrusion and Spray Drying Techniques for Preparation of Liquid and Solid Cannabidiol Nano-Structured Lipid Carriers Formulations. | AAPS PharmSciTech | 2025 | https://conductscience.org/library/papers/41219654 | PubMed |
| 40917849 | Nanotechnology and natural killer cell immunotherapy: synergistic approaches for precise immune system adjustment and targeted cancer treatment in gastrointestinal tumors. | Front Med (Lausanne) | 2025 | https://conductscience.org/library/papers/40917849 | PubMed |
| 40859982 | Panobinostat-Loaded Albumin Nanoparticles for the Treatment of Pancreatic Cancer. | J Drug Deliv Sci Technol | 2025 | https://conductscience.org/library/papers/40859982 | PubMed |
| 40801679 | Nanocarriers for Combination Therapy in Pancreatic Ductal Adenocarcinoma: A Comprehensive Review. | Nanomaterials (Basel) | 2025 | https://conductscience.org/library/papers/40801679 | PubMed |
| 40720073 | Redox Signaling Disruption and Antioxidants in Toxicology: From Precision Therapy to Potential Hazards. | Cell Biochem Biophys | 2025 | https://conductscience.org/library/papers/40720073 | PubMed |
| 40699702 | Albumin: A Review of Market Trends, Purification Methods, and Biomedical Innovations. | Curr Issues Mol Biol | 2025 | https://conductscience.org/library/papers/40699702 | PubMed |
| 40585000 | Riding the wave of innovation: nanotechnology in nucleic acid-based cancer therapy. | 3 Biotech | 2025 | https://conductscience.org/library/papers/40585000 | PubMed |
| 40547806 | An overview of the feasibility of nanomedicine in pancreatic cancer theranostics. | Explor Target Antitumor Ther | 2025 | https://conductscience.org/library/papers/40547806 | PubMed |
| 40202672 | Comprehensive insights into pancreatic cancer treatment approaches and cutting-edge nanocarrier solutions: from pathology to nanomedicine. | Naunyn Schmiedebergs Arch Pharmacol | 2025 | https://conductscience.org/library/papers/40202672 | PubMed |
| 39682281 | Sirtuins as Key Regulators in Pancreatic Cancer: Insights into Signaling Mechanisms and Therapeutic Implications. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/39682281 | PubMed |
| 39331254 | The antioxidant and selective apoptotic activities of modified auraptene-loaded graphene quantum dot nanoparticles (M-AGQD-NP). | Discov Oncol | 2024 | https://conductscience.org/library/papers/39331254 | PubMed |
Genes63
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37765331
GET https://conductscience.org/api/papers/v1/37765331/references?page=2